Financial Performance Highlights (Q1 FY27)

Consolidated Financials

  • Operating Revenue: ₹26,836 Mn, representing 78.0% YoY growth from ₹15,073 Mn in Q1 FY26
  • EBITDA: ₹5,052 Mn, representing 40.0% YoY growth from ₹3,607 Mn in Q1 FY26
  • EBITDA Margin: 18.8% compared to 23.9% in Q1 FY26
  • PAT: ₹2,073 Mn, representing 5.7% YoY growth from ₹1,961 Mn in Q1 FY26
  • PAT Margin: 7.7% compared to 13.0% in Q1 FY26
  • QoQ Performance: Revenue increased 3.5% QoQ, EBITDA decreased 6.4% QoQ, PAT decreased 9.2% QoQ

Geographic Segment Performance

  • India Revenue: ₹13,247 Mn, 17.0% YoY growth from ₹11,326 Mn, 5.9% QoQ growth
  • Cayman Revenue: ₹5,514 Mn, 38.9% YoY growth from ₹3,968 Mn, 1.8% QoQ decline
  • UK Revenue: ₹8,257 Mn, 2.1% QoQ growth (no YoY comparison available as UK operations were not part of company in previous year)

Currency Conversion Notes

  • Cayman & UK numbers converted from USD to INR at 94.71 for YTD FY27 and 88.31 for FY26
  • UK numbers converted from GBP to USD at 1.34 for YTD FY27
  • Consolidated Revenue & EBITDA numbers adjusted for Inter-company eliminations

Capital Structure and Debt Position

As of June 30, 2026:

  • Total Borrowings less Cash & Bank Balance and Investments: ₹19,671 Mn
  • Net Debt to Equity Ratio: 0.42
  • Foreign Currency Denominated Debt: US$115 Mn and GBP £150 Mn

Operational Highlights for Q1 FY27

Narayana Institute of Cardiac Sciences, Bangalore

  • Performed 2,137 cardiac surgeries in Q1 FY27
  • Performed 19 Pulse Field Ablation procedures in June 2026 for Atrial Fibrillation since launch in India

Narayana Hospital, Gurugram

  • Operationalized CUVIS Ortho Robotic System in Q1 FY27
  • Operationalized Thulium Laser System for advanced minimally invasive urological procedures

Robotic Surgery Procedures

Performed wide spectrum of robotic surgeries across units in Q1 FY27 including:

  • Robotic CBD Exploration
  • Robot-assisted Hiatus & Ventral Hernia Repair + Paraumbilical Lump Excision
  • Robotic Simple Prostatectomy
  • Robotic Cytoreductive Surgery

Management Commentary

Dr. Emmanuel Rupert, Managing Director and Group CEO, commented:

  • Q1 FY27 started strong with all geographies delivering robust performance
  • India delivered robust growth despite seasonally weaker quarter, driven by higher patient footfall, focus on high-end complex procedures, and strong underlying customer demand
  • Expanding Integrated Care ecosystem (clinics and insurance) reinforcing momentum and enhancing patient outreach
  • Cayman business performing well with hospitals supported by One Health insurance platform
  • UK business (acquired recently) in third quarter under NH, remaining stable with integration progressing well and separation from erstwhile parent approaching completion
  • Confident of growth potential for UK business and delivering on expectations for the year

Company Background

Narayana Hrudayalaya Limited:

  • Founded in 2000 by Dr. Devi Prasad Shetty
  • Headquartered in Bengaluru
  • Network of 55 Healthcare facilities across India, Cayman Islands, and United Kingdom
  • Over 5,900 operational beds with capacity of over 6,200 beds

Investor Conference Call Details

  • Date: Monday, August 3rd, 2026
  • Time: 03:00 PM IST
  • Purpose: To discuss Q1 FY27 results ended June 30, 2026
  • Conference Call Link: Provided as "Click here to Join the conference Call"
  • Transcript: Will be uploaded on company website www.narayanahealth.org